DEC 01, 2021 7:07 AM PST

Is GDF-15 a Valuable Biomarker for Congestive Heart Failure?

Congestive Heart Failure (CHF) is a serious medical condition that results in the heart not being able to pump to meet the body's demands successfully. CHF is generally caused by long-standing chronic diseases such as diabetes, high blood pressure, and ischemic heart disease. Notably, it is associated with significant mortality and consumption of healthcare resources. Between 2000 and 2010, it was estimated that 1 million hospitalizations were related to CHF in the United States. Due to the serious nature of CHF, it is necessary to have a reliable biomarker to estimate the outcome of this disease. Traditionally laboratory markers such as B-type Natriuretic Peptide (BNP) have been used to diagnose and predict outcomes in heart failure. Although valuable, BNP is impacted by other factors such as age and certain medical conditions, limiting its clinical usefulness.

Previous animal studies have demonstrated that Growth Differentiation Factor-15 (GDF-15) is upregulated in response to cardiac stress. Certain studies have also indicated that levels are higher in human patients with CHF. As such, investigators have performed a meta-analysis to determine whether GDF-15 can serve as a reliable biomarker in the prognostic evaluation of CHF.

The meta-analysis included ten studies with over 6 thousand participants. Rigorous bias assessment was performed, and publication bias was controlled using various methods. In addition, all included studies were deemed high quality based on Newcastle-Ottawa-Scale methodology. Results indicated that all-cause mortality significantly increased with increasing levels of GDF-15 in patients with ischemic CHF. The risk of death was also more strongly associated with patients that had CHF with reduced ejection fraction. Limitations of this analysis include heterogeneity across eligible studies, possibly due in part to factors such as comorbidities among study participants and different assay methods for measuring GDF-15. 

This evidence strongly suggests that GDF-15 may serve as a useful biomarker in the prognostication of CHF. Further studies should focus on factors such as GDF-15 levels for stratifying patients into different risk categories. In addition, the impact of age and medical comorbidities on the prognostic utility of GDF-15 should also be evaluated. 

 

 

Sources: CDC, Circulation Research, Frontiers in Cardiovascular Medicine

About the Author
  • Dr. Christopher DiMaio is a Science Writer at Labroots. He received his MD from Penn State College of Medicine in 2014. His academic and professional interests include Neuroscience, Behavioral health, Immunology, and Healthcare improvement, among others. He is an active part of his community.
You May Also Like
AUG 15, 2021
Neuroscience
Cholesterol in the Brain Linked to Alzheimer's Plaques
AUG 15, 2021
Cholesterol in the Brain Linked to Alzheimer's Plaques
Cholesterol levels in the brain tightly regulate the production of amyloid-beta plaques in the brain, a key feature of A ...
AUG 24, 2021
Health & Medicine
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
AUG 24, 2021
Cannabis Use and Cardiovascular Disease- A Lesson in Causality
As the march toward legalization of Marijuana use continues amidst ongoing debate, more attention has been paid to the i ...
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
NOV 09, 2021
Cardiology
How Mutations in a Huge Gene Can Cause a Common Heart Disorder
NOV 09, 2021
How Mutations in a Huge Gene Can Cause a Common Heart Disorder
Hundreds of thousands of Americans are thought to have dilated cardiomyopathy (DCM), a progressive disorder in which the ...
NOV 17, 2021
Neuroscience
Drinking Tea and Coffee Linked to Reduced Dementia and Stroke Risk
NOV 17, 2021
Drinking Tea and Coffee Linked to Reduced Dementia and Stroke Risk
Drinking 4-6 cups of coffee or tea is linked to a lower risk of stroke and dementia. The corresponding study was publish ...
Loading Comments...